ArticleCancers2022

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.

Chia-Yu Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.